CHESON: Revised Response Criteria for Malignant Lymphoma (2007)
CHESON standardizes the response criteria for malignant lymphomas. CHESON criteria are used to interpret and compare clinical trial data for approval of new therapeutic agents by regulatory agencies. It provides uniform end points for clinical trials, allowing for comparisons among trials, facilitating the identification of more effective therapies, and aiding the approval process for new agents by regulatory agencies. Standardization allows for the data from multiple trials to be compared with each other (e.g. apples to apples comparison).
CHESON standardizes the response criteria for malignant lymphomas. CHESON criteria are used to interpret and compare clinical trial data for approval of new therapeutic agents by regulatory agencies. It provides uniform end points for clinical trials, allowing for comparisons among trials, facilitating the identification of more effective therapies, and aiding the approval process for new agents by regulatory agencies. Standardization allows for the data from multiple trials to be compared with each other (e.g. apples to apples comparison).